SCHEMBL2803524

SCHEMBL2803524

Clc1ccc(C2Cc3cnc(NCCc4ccccc4)nc3-c3ccccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.51
FGFR2 P21802 2/20 0.51
CSF1R P07333 1/20 0.46
FGFR3 P22607 1/20 0.46
MYLK Q15746 1/20 0.40
HRH4 Q9H3N8 2/20 0.38
HRH1 P35367 1/20 0.38
ADORA1 P30542 3/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CETP P11597 1/20 0.38
CHRNA7 P36544 1/20 0.38
MRGPRX1 Q96LB2 3/20 0.37
AXL P30530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808244 0.93 FGFR1 (0.59) FGFR1FGFR2CSF1RFGFR3HRH4
SCHEMBL2803416 0.92 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3MYLK
SCHEMBL2803912 0.92 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2803281 0.91 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2803137 0.91 FGFR1 (0.46) FGFR1FGFR2CSF1RFGFR3MYLK
SCHEMBL2807724 0.90 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3KDM4E
SCHEMBL2805563 0.87 FGFR1 (0.55) FGFR1FGFR2CSF1RFGFR3TYRO3
SCHEMBL2804023 0.86 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3HRH4
SCHEMBL2802654 0.86 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3HRH4
SCHEMBL2806391 0.85 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.